Photodynamic therapy of residual or recurrent basal cell carcinoma after radiotherapy using topical 5-aminolevulinic acid or methylester aminolevulinic acid

Acta Oncologica

Volumn 39, Issue 5, 2000, Pages 605-609

  Soler, A M ^a   Warloe, T ^a   Tausjo, J ^a   Giercksky, K E ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; METHYLESTER AMINOLEVULINIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT CANCER; TREATMENT INDICATION;

EID: 0033770888     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600750013285     Document Type: Article

References (17)

1. Use of Mohs micrographic surgery to establish quantitative proof of heightened tumor spread in basal cell carcinoma recurrent following radiotherapy
2. Basal cell carcinoma recurring after radiotherapy: A unique, difficult subclass of recurrent basal cell carcinoma
3. 5-Aminolevulinic acid - Based photodynamic therapy. Clinical research and future challenges
4. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience
5. Treatment of superficial basal cell carcinomas using topically applied delta-aminolevulinic acid and a filtered xenon lamp
6. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid
7. Photodynamic therapy of epithelial skin turnouts using delta-aminolevulinic acid and desferrioxamine
8. Photodynamic therapy for basal cell carcinoma: Effect of tumor thickness and duration of photosensitizer application on response
9. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma
10. Photodynamic herapy of malignant lesions of the skin mediated by topical application of 5-aminolevulinic acid in combination with DMSO and EDTA
11. Photodynamic therapy with 5-aminolevulic acid induced porphyrins and DMSO/EDTA for basal cell carcinoma
12. Curettage and topical ALA-based photodynamic therapy for nodular ulcerative basal cell carcinomas
13. Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin
14. Preferential relative porphyrin enrichment in solar keratosis upon topical application of delta-aminolevulinic acid methylester
15. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy
16. The recurrent basal cell epitelioma
17. Photodynamic therapy by topical aminolevulinic acid, dimethylsulfoxide and curettage in nodular basal cell carcinoma. One year follow-up study